Combination of cdk4/6 and mtor inhibitors suppressed doxorubicin-resistant osteosarcoma in a patient-derived orthotopic xenograft mouse model: A translatable strategy for recalcitrant disease
Hiromichi Oshiro, Yasunori Tome, Kentaro Miyake, Takashi Higuchi, Norihiko Sugisawa, Fuminori Kanaya, Kotaro Nishida, Robert M. Hoffman
Dive into the research topics of 'Combination of cdk4/6 and mtor inhibitors suppressed doxorubicin-resistant osteosarcoma in a patient-derived orthotopic xenograft mouse model: A translatable strategy for recalcitrant disease'. Together they form a unique fingerprint.